An Open-label Single-arm Multicentre Non-controlled Phase 3 a Trial Investigating Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Untreated Patients With Haemophilia B (FIX Activity Below or Equal to 2 Percent)

Name: An Open-label Single-arm Multicentre Non-controlled Phase 3 a Trial Investigating Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Untreated Patients With Haemophilia B (FIX Activity Below or Equal to 2 Percent)
Creator: Vivli
Published: 2025-12-05 14:10:57
License: 暂无描述

DataCite Commons2025-12-05 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012043/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This trial is conducted globally. The aim of the trial is to investigate the safety and efficacy of nonacog beta pegol (N9-GP) in previously untreated patients with Haemophilia B.

提供机构：

Vivli

创建时间：

2025-12-05